APA (7th ed.) Citation

SJ, S., A, B., M, K., B, M., P, P., A, S., . . . M, C. (2025). Chemoresistance of TP53 mutant acute myeloid leukemia requires the mevalonate byproduct, geranylgeranyl pyrophosphate, for induction of an adaptive stress response. Leukemia, 39(9), 2087. https://doi.org/10.1038/s41375-025-02668-6

Chicago Style (17th ed.) Citation

SJ, Skuli, et al. "Chemoresistance of TP53 Mutant Acute Myeloid Leukemia Requires the Mevalonate Byproduct, Geranylgeranyl Pyrophosphate, for Induction of an Adaptive Stress Response." Leukemia 39, no. 9 (2025): 2087. https://doi.org/10.1038/s41375-025-02668-6.

MLA (9th ed.) Citation

SJ, Skuli, et al. "Chemoresistance of TP53 Mutant Acute Myeloid Leukemia Requires the Mevalonate Byproduct, Geranylgeranyl Pyrophosphate, for Induction of an Adaptive Stress Response." Leukemia, vol. 39, no. 9, 2025, p. 2087, https://doi.org/10.1038/s41375-025-02668-6.